JORDAN MCCLONEY: Open Payments
NPI 1306440003 · LEON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 19 payments from 12 companies in 2025. Trend: 2023 $241 · 2024 $259 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Amgen Inc. | 1 | $49 |
| Insulet Corporation | 1 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| PFIZER INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| ABBVIE INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: JARDIANCE, AUSTEDO XR, KRYSTEXXA, OMNIPOD, REXULTI, Kerendia, PREVNAR 20, CAPVAXIVE.
Industry payments across IA — which companies pay providers there.
